Multiple Myeloma Hub‘s summary of the iStopMM key talks and posters at ASH 2021

In an article in CancerTherapyAdvisor.com the iStopMM study and it‘s results are covered. Results from the study were presented at the 2021 American Society of

Myeloma patients have an increased risk of severe COVID-19. MGUS, the precursor of myeloma, has previously been associated with an increased risk of infections, the

In May 2021 iStopMM reached an important milestone, with the publication of the first results of the screening study in its first article, “Iceland screens,